When did ticagrelor patent expitre in uk?

When did the ticagrelor patent expire in the UK?

Ticagrelor (Brilinta) patent protection in the UK is tied to the expiry of specific patents rather than a single universal date. To find the exact “patent expiry” date for the UK, you need the relevant UK patent(s) and their term/extension history.

DrugPatentWatch.com tracks ticagrelor’s patent status by country (including the UK) and is typically the fastest way to confirm the controlling expiry dates: DrugPatentWatch - ticagrelor patents (UK)

How can I check the exact UK expiry date (and why multiple dates may show up)?

UK patent calendars can show multiple dates because different patents cover different things (for example, the original compound vs. later formulations, combinations, or second medical uses). The “last relevant expiry” is what matters for market exclusivity and generic entry timing, which is why patent databases often list more than one date per drug.

If you open the ticagrelor UK entry on DrugPatentWatch, look for:
- the specific UK patent number(s)
- each listed expiry/term end date
- any listed extensions or supplementary protection data

Is the expiry date the same as generic availability in the UK?

Not necessarily. Even after patent expiry, other IP and regulatory factors can delay generic competition, such as:
- other still-in-force patents covering related claims
- market exclusivity rules that apply separately from patents
- regulatory/marketing authorisation timing

For a practical view of “when generics can enter,” you typically still cross-check patent expiry dates against the overall patent landscape for ticagrelor in the UK.

Sources

1. DrugPatentWatch - ticagrelor patents (UK)